| Financial Year |
March 31 2023 |
| Monetary Funds |
395,545,161.51 |
| Held-for-trading Financial Assets |
393,409,657.13 |
| Notes Receivable |
8,445,120.44 |
| Accounts Receivable |
326,971,561.03 |
| Advances to Suppliers |
17,863,016.87 |
| Other Receivables |
2,087,028.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
217,506,790.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,337,264.91 |
| Total Current Assets |
1,368,615,054.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,687,659.77 |
| Fixed Assetes |
1,160,945,014.58 |
| Under-construction Projects |
356,062,252.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,180,961.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
330,383.45 |
| Deferred Income Tax Assets |
13,947,447.05 |
| Other Non-Current Assets |
6,676,345.06 |
| Sub-Total of Non-Current Assets |
1,655,830,063.91 |
| Total Assets |
3,024,445,118.45 |
| Short-Term Loans |
257,017,934.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
214,870,673.95 |
| Accounts Payable |
262,293,356.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,808,784.13 |
| Taxes Payable |
10,038,369.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,485,094.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
9,889,219.96 |
| Sub-Total of Current Liabilities |
811,454,095.08 |
| Long-term Loans |
-- |
| Bonds Payable |
579,014,243.01 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,291,046.53 |
| Other Non-Current Liabilities |
1,690,000.00 |
| Sub-Total of Non-Current Liabilities |
656,702,278.98 |
| Total Liabilities |
1,468,156,374.06 |
| Paid-In Capital(Or Share Stock) |
166,054,574.00 |
| Capital Surplus |
877,083,187.43 |
| Surplus Reserve |
50,889,318.96 |
| LESS:Treasury Stock |
55,730,993.28 |
| Undistributed Profits |
391,076,854.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,556,288,744.39 |
| Owner's Equity（Stockholder's Equity） |
1,556,288,744.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,024,445,118.45 |
